Encorafenib, also known as Encorafenib, is a targeted drug used to treat specific types of lesions. It is mainly used for the treatment of BRAF-V600E or V600K mutation-positive unresectable or metastatic melanoma, and BRAF-V600E mutation-positive metastatic colorectal lesions. By inhibiting the activity of BRAF protein, Encorafenib prevents the growth and spread of diseased cells.
Efficacy of Cinsolfenib Confirmelfinil?
Encorafenib is a highly potent BRAF inhibitor primarily for the treatment of BRAF-V600E or V600K mutation-positive unresectable or metastatic melanoma and BRAF-V600E mutation-positive metastatic colorectal lesions. It prolongs the survival of patients by inhibiting the activity of BRAF protein and preventing the growth and spread of diseased cells.
Treatment of melanoma
Encorafenib is indicated in combination with bimetinib for the treatment of unresectable or metastatic melanoma positive for BRAF-V600E or V600K mutations. The recommended dose is 450 mg (6 capsules of 75 mg) once daily until disease progression or unacceptable toxicity. This combination significantly improved progression-free survival and overall survival.
The drug has not yet been marketed in China
Encorafenib is not yet available in China and is not covered by China's medical insurance. Patients can purchase the drug through formal medical service institutions or cross-border e-commerce platforms. The price of the 75mg*42 capsule format is about $2,135, while the price of the 75mg*168 capsule format is about $6,988. Patients should pay attention to the authenticity and production date of the drug when purchasing, and avoid buying counterfeit or inferior drugs.
Encorafenib has performed well in the treatment of specific types of lesions, but patients need to be aware of its possible side effects and related precautions during use, and we will introduce the side effects and precautions of Encorafenib in detail.
Side effects and precautions for Kangsaffenib?
Encorafenib excels in treating lesions, but patients may experience some side effects during use. Common side effects include fatigue, nausea, vomiting, abdominal pain, and joint pain, and patients also need to be aware of the effects of the drug on the heart, eyes, and skin.
Common side effects
Common side effects of Encorafenib include fatigue, nausea, vomiting, abdominal pain, and joint pain. These side effects are usually mild to moderate, and patients can be relieved by adjusting their diet or using symptomatic medications. If side effects are severe or persistent, patients should consult their doctor promptly.
Heart and eye effects
Encorafenib may cause QT interval prolongation and uveitis. Prolonged QT interval may cause arrhythmias, and patients should have their ECG monitored regularly. Uveitis may cause vision loss or eye discomfort, patients should have regular eye exams and stop the drug and consult a doctor as soon as visual symptoms appear.
The use of Encorafenib needs to be tailored to the specific situation of the patient, especially for certain contraindicated populations.
Contraindications to Encorafenib
Encorafenib is not suitable for all patients, and certain groups of people should avoid it. In particular, patients with severe heart disease, prolonged QT interval, or uveitis need to be used with extreme caution when using Encorafenib.
Patients with severe heart disease
Encorafenib may cause QT interval prolongation, so patients with severe heart disease or QT interval prolongation should avoid the drug. If a patient develops arrhythmias or other cardiac symptoms during the medication, the drug should be discontinued immediately and a doctor should be consulted.
Patients with uveitis
Encorafenib can cause uveitis, so people with uveitis or other eye diseases should avoid the drug. If the patient experiences vision loss or eye discomfort during the medication, the drug should be discontinued immediately and a doctor should be consulted.
Encorafenib is a prescription drug, and patients should follow their doctor's instructions and regularly monitor their heart, eyes, and skin conditions to prevent possible serious adverse effects.
